EDITORIAL POLICIES AND PRACTICES

Authorship

Hylonome Publications has adopted for all its journals the requirements for authorship and acknowledgment of contributors recommended by the International Committee of Medical Journal Editors (ICMJE) in the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.

Please refer to the instructions for authors for a more detailed description regarding the compliance of submitted manuscripts to ICMJE

Human Subjects

Research carried out with human subjects must comply with the World Medical Association Declaration of Helsinki — Ethical Principles for Medical Research Involving Human Subjects. A statement to this effect must appear in the Methods section of the manuscript, including the name of the body that gave approval. When reporting clinical trials, the information required by the CONSORT checklist, as well as a flow diagram in CONSORT format must be provided.

Use of Animals in Research

Approval for research in animals by the appropriate institutional animal care and oversight committee must be indicated in the Methods, along with full husbandry and experimental details (e.g. strain, sex, replicate number) as indicated by the Animal Research Reporting of In Vivo Experiments (ARRIVE) checklist.

Open Access Statement

Authors submitting a manuscript to Hylonome Publications agree that, if accepted, it will be published under the terms of Creative Common License CC BY-NC-SA 4.0 (Attribution-NonCommercial-ShareAlike) This means that the article will be immediately free for everyone to read, and users are free to: copy and redistribute the material in any medium or format, remix, transform, and build upon the material, under the following terms:

Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
NonCommercial: Users may not use the material for commercial purposes.
ShareAlike: If users remix, transform, or build upon the material, they must distribute their contributions under the same license as the original.

We use cookies to improve user experience. Choose what cookies you allow us to use. You can read more about our Cookie Policy here.